EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

PARP inhibitors: its role in treatment of cancer

Alice Chen

Chinese Journal of Cancer · 05.07.2011 · 463-471

DOI: 10.5732/cjc.011.10111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.07.2011. Verfasst von Alice Chen. Beteiligte Einrichtung: Division of Cancer Treatment and Diagnosis National Institutes of Health, National Cancer Institute, Rockville, MD 20852, USA. chenali@mail.nih.gov. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 170-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsBenzamidesBenzimidazolesBreast NeoplasmsDNA Breaks, Double-StrandedDNA Breaks, Single-StrandedDNA End-Joining RepairDNA RepairEnzyme InhibitorsFemaleGenes, BRCA1Genes, BRCA2Homologous RecombinationHumansMutationOvarian NeoplasmsPhthalazinesPiperazinesPoly(ADP-ribose) Polymerases

Substanzen

BenzamidesBenzimidazolesEnzyme InhibitorsPhthalazinesPiperazinesPoly(ADP-ribose) Polymerase InhibitorsveliparibiniparibPoly(ADP-ribose) Polymerasesolaparib

Autor:innen und Institutionen

  • Division of Cancer Treatment and Diagnosis National Institutes of Health, National Cancer Institute, Rockville, MD 20852, USA. chenali@mail.nih.gov

Zitieren

APA

Chen, A. (2011). PARP inhibitors: its role in treatment of cancer. Chinese Journal of Cancer, 463-471. https://doi.org/10.5732/cjc.011.10111

Vancouver

Chen A. PARP inhibitors: its role in treatment of cancer. Chinese Journal of Cancer. 2011:463-471. doi:10.5732/cjc.011.10111

BibTeX
@article{Chen2011,
  author = {Chen, Alice},
  title = {PARP inhibitors: its role in treatment of cancer},
  journal = {Chinese Journal of Cancer},
  year = {2011},
  pages = {463--471},
  doi = {10.5732/cjc.011.10111}
}
Kostenlos starten →